CVS Health Corp (CVS · NYSE)
CVS · MARKET VIEW
Market view · as of Jul 27, 2026
Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
95.9%
-2.0% vs 52w high · +3.6% 1mo
Price (last ~year)
CVS Health reported $100.43B in revenue for the quarter ending March 31, 2026, marking a 63.1% year-over-year increase in earnings and a fourth consecutive quarter of beating analyst expectations. With a market capitalization of $137.47B, the healthcare conglomerate maintains $78.34B in total debt, representing a 5.1x debt-to-EBITDA ratio. Shares recently traded at $107.74, compared to the consensus analyst price target of $112.19.
Valuation
- Market cap
- $137.47B
- P/E
- 47.25
- PEG
- 0.303
- P/B
- 1.775
- P/S
- 0.339
- EV/EBITDA
- 18.33
- Beta
- 0.598
- Analyst target
- $112.19
Quality & returns
- Gross margin
- 13.4%
- Operating margin
- 4.1%
- Profit margin
- 0.7%
- ROE
- 3.8%
- ROA
- 2.7%
Price movement
- Last
- $107.74
- 1-month
- +3.6%
- 3-month
- +33.9%
- RSI (14)
- 69
- vs SMA200
- +30.4%
- 52-wk position
- 95.9% -2.0% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $100.43B | $4.68B | $2.94B | $5.83B |
| 2025-12-31 | $105.69B | $2.11B | $2.94B | $3.29B |
| 2025-09-30 | $102.87B | $-3.21B | $-3.98B | $-1.56B |
| 2025-06-30 | $98.92B | $2.38B | $1.02B | $3.58B |
Recent news
- Neutral CVS Health stock holds the line as earnings stay central · 2026-07-27
- Neutral Novo Nordisk A/S $NVO Shares Sold by PNC Financial Services Group Inc. · 2026-07-26
- Neutral Oncology Institute Inc (TOI) Earnings Forecast: Future EPS & Revenue Growth Estimates · 2026-07-26
- Somewhat-Bullish FLGT|Fulgent Genetics Inc|Price:19.670|Chg%:-0.310 · 2026-07-26
- Somewhat-Bullish Cryo-Cell International Inc (CCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates · 2026-07-26
- Somewhat-Bullish XGN|Exagen Inc|Price:4.680|Chg%:-0.270 · 2026-07-25
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)